- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/99 - Enzyme inactivation by chemical treatment
Patent holdings for IPC class C12N 9/99
Total number of patents in this class: 506
10-year publication summary
31
|
25
|
23
|
26
|
28
|
38
|
18
|
21
|
21
|
12
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2703 |
25 |
The Regents of the University of California | 19803 |
15 |
Shionogi & Co., Ltd. | 868 |
13 |
Wyeth LLC | 652 |
10 |
Northwestern University | 3357 |
8 |
Keio University | 1089 |
7 |
Riken | 1688 |
7 |
Janssen Pharmaceutica N.V. | 3432 |
5 |
Kao Corporation | 4941 |
5 |
National Research Council of Canada | 1547 |
5 |
National University Corporation Okayama University | 475 |
5 |
Pharma Foods International Co., Ltd | 53 |
5 |
Toray Industries, Inc. | 6886 |
4 |
The Trustees of Columbia University in the City of New York | 3558 |
4 |
Cepheid | 343 |
4 |
Dana-Farber Cancer Institute, Inc. | 2548 |
4 |
Incyte Corporation | 1005 |
4 |
Incyte Holdings Corporation | 655 |
4 |
National University Corporation Hokkaido University | 1336 |
4 |
Nippi, Incorporated | 54 |
4 |
Other owners | 364 |